NASCENT BIOTECH, INC. — Revenue by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/8eb243b2-ace4-4d7c-9960-e5dd84474928/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2022 | $0 | 2022-04-01 – 2023-03-31 | evidence 0001477932-23-004894 |
| FY 2021 | $1.0M | 2021-04-01 – 2022-03-31 | evidence 0001477932-22-004396 |
| FY 2020 | $750.0k | 2020-04-01 – 2021-03-31 | evidence 0001477932-21-004504 |
| FY 2019 | $0 | 2019-04-01 – 2020-03-31 | evidence 0001477932-20-003479 |
| FY 2018 | $0 | 2018-04-01 – 2019-03-31 | evidence 0001477932-20-003479 |
| FY 2016 | $3.0M | 2016-04-01 – 2017-03-31 | evidence 0001477932-17-003089 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
NASCENT BIOTECH, INC. — all facts · Net Income · Operating Income